Amikacin pharmacokinetics in pediatric patients with malignancy.

The pharmacokinetics of amikacin were evaluated in 50 pediatric patients (1 to 17 years of age) with malignancies and normal renal function. Dosage regimens of 5 mg/kg per dose were administered intravenously (i) over 30 min every 8 h, (ii) over 60 min every 8 h, and (iii) over 60 min every 6 h. Adm...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Cleary, T G, Pickering, L K, Kramer, W G, Culbert, S, Frankel, L S, Kohl, S
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 1979
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352961/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/533263/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.16.6.829
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!